biomarker testing

Review

NGS Testing in Non–Small Cell Lung Cancer

09/19/2023

Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...

Winston Wong, PharmD, and Gordon...

09/19/2023

Journal of Clinical Pathways

Videos

Real-World Biomarker Testing, Treatment Patterns in CLL/SLL

12/17/2020

Anthony Mato, MD, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with CLL in the clinical practice setting, using the informCLL prospective registry.

Anthony Mato, MD, discusses...

12/17/2020

Journal of Clinical Pathways

Research Reports

Use of Biomarker Testing in Lung Cancer Among Puerto Rico and Florida Physicians: Results of a Comparative Study

10/18/2019

Steven K. Sutton , PhD;

Alberto Chiappori , MD;

Iffat Alam ;

Vani N. Simmons , PhD;

Matthew B. Schabath , PhD;

Teresita Muñoz-Antonia , PhD;

Gwendolyn P. Quinn , PhD;

Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...

...

10/18/2019

Journal of Clinical Pathways